The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

BACKGROUND/AIMS: We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy. METHODS: A total of 123 patients aged > 65 years with AML who received decitabine were eligible. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mihee, Kim, TaeHyung, Ahn, Seo-Yeon, Lee, Jun Hyung, Park, Ju Heon, Shin, Myung-Geun, Jung, Sung-Hoon, Song, Ga-Young, Yang, Deok-Hwan, Lee, Je-Jung, Choi, Seung Hyun, Kim, Mi Yeon, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Kim, Dennis Dong Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338247/
https://www.ncbi.nlm.nih.gov/pubmed/37291838
http://dx.doi.org/10.3904/kjim.2022.396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338247/
https://www.ncbi.nlm.nih.gov/pubmed/37291838
http://dx.doi.org/10.3904/kjim.2022.396

Ejemplares similares